1. "Gregory Riely"
  2. "Graduate Medical Education"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (11)
  3. Correspondence (1)
  4. Editorial (1)
Groups
  1. Department of Medicine (27)
  2. Graduate Medical Education (27)
  3. Solid Tumor Oncology Division (27)
  4. Thoracic Oncology (27)
  5. GSK Faculty (21)
  6. GME, Medicine (20)

More Groups

People
  1. Gregory Riely (27)
  2. Charles Rudin (13)
  3. Marc Ladanyi (12)
  4. Mark Kris (10)
  5. Adam Schoenfeld (8)
  6. Jorge Reis-Filho (8)

More People

Years
  1. 2023 (12)
  2. 2022 (7)
  3. 2021 (4)
  4. 2020 (3)
  5. 2019 (1)
Publications
  1. Clinical Cancer Research (5)
  2. Journal of Clinical Oncology (5)
  3. Journal of Thoracic Oncology (4)
  4. International Journal of Radiation Oncology, Biology, Physics (3)
  5. Annals of Oncology (1)
  6. Cancer Cell (1)

More Publications

Publishers
  1. Elsevier Inc. (7)
  2. American Association for Cancer Research (6)
  3. American Society of Clinical Oncology (5)
  4. Cell Press (2)
  5. Oxford University Press (2)
  6. American Medical Association (1)

More Publishers

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer
    Journal Article

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Carrot-Zhang, J.; Fong, C.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Lorlatinib tolerability and association with clinical outcomes in patients with advanced ALK- or ROS1-rearranged NSCLC: A brief report
    Journal Article

    Thummalapalli, R.; Choudhury, N. J.; Ehrich, F.; Beardslee, T.; Brazel, D.; Zhang, S. S.; Merchant, S.; Chen, M. F.; Heller, G.; Ramalingam, S. S.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • The GENIE BPC NSCLC cohort: A real-world repository integrating standardized clinical and genomic data for 1,846 patients with non-small cell lung cancer
    Journal Article

    Choudhury, N. J.; Lavery, J. A.; Brown, S.; de Bruijn, I.; Jee, J.; Tran, T. N.; Rizvi, H.; Arbour, K. C.; Whiting, K.; Shen, R.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Clinical outcomes and genomic landscape of patients (pts) with EGFR-mutant lung cancer (EGFR+ LC) with central nervous system (CNS) metastases (mets)
    Meeting Abstract

    Sui, J. S. Y.; Wilcox, J.; Tischfield, S.; Choudhury, N. J.; Riely, G. J.; Kris, M. G.; Boire, A. A.; Yu, H. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Large-scale clinicogenomic models of solid tumor CNS metastasis
    Meeting Abstract

    Jee, J.; Luthra, A.; Fong, C.; Pichotta, K.; Tran, T.; Altoe, M.; Miller, A.; Shen, R.; Berger, M. F.; Sanchez-Vega, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Randomized phase 2 placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis
    Journal Article

    Rimner, A.; Moore, Z. R.; Lobaugh, S.; Geyer, A.; Gelblum, D. Y.; Abdulnour, R. E. E.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Cuaron, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save